FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HAN, Z.
Right arrow Articles by ZHANG, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HAN, Z.
Right arrow Articles by ZHANG, L.
(The FASEB Journal. 2001;15:988-994.)
© 2001 FASEB

Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells

ZEQIU HAN*,1, JIAN NI{dagger},1, PATRICK SMITS**,1, CHARLES B. UNDERHILL*, BIN XIE*, YIXIN CHEN§, NINGFEI LIU*, PRZEMKO TYLZANOWSKI, DAVID PARMELEE{dagger}, PING FENG{dagger}, IVAN DING{ddagger}, FENG GAO*, REINER GENTZ{dagger}, DANNY HUYLEBROECK, JOZEF MERREGAERT**,2 and LURONG ZHANG*,23

* Department of Oncology, Georgetown University Medical Center, Washington, D.C. 20007, USA;
{dagger} Human Genome Sciences, Rockville, Maryland 20850, USA;
{ddagger} Department of Radiology, Rochester University Medical Center, Rochester, New York 14642, USA;
§ Department of Biology, Xiamen University, China;
Laboratory of Molecular Biology (Celgen) and Department of Cell Growth, Differentiation and Development, Flanders Interuniversity Institute of Biotechnology (VIB), University of Leuven, Leuven, Belgium; and
** Laboratory of Molecular Biotechnology, Department of Biochemistry, Universiteitsplein 1, Wilrijk, Belgium

3Correspondence: Department of Oncology, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, D.C. 20007, USA. E-mail: zhangl{at}georgetown.edu

Tumor growth and metastasis are critically dependent on the formation of new blood vessels. The present study found that extracellular matrix protein 1 (ECM1), a newly described secretory glycoprotein, promotes angiogenesis. This was initially suggested by in situ hybridization studies of mouse embryos indicating that the ECM1 message was associated with blood vessels and its expression pattern was similar to that of flk-1, a recognized marker for endothelium. More direct evidence for the role of ECM1 in angiogenesis was provided by the fact that highly purified recombinant ECM1 stimulated the proliferation of cultured endothelial cells and promoted blood vessel formation in the chorioallantoic membrane of chicken embryos. Immunohistochemical staining with specific antibodies indicated that ECM1 was expressed by the human breast cancer cell lines MDA-435 and LCC15, both of which are highly tumorigenic. In addition, staining of tissue sections from patients with breast cancer revealed that ECM1 was present in a significant proportion of primary and secondary tumors. Collectively, the results of this study suggest that ECM1 possesses angiogenic properties that may promote tumor progression.—Han, Z., Ni, J., Smits, P., Underhill, C. B., Xie, B., Chen, Y., Liu, N., Tylzanowski, P., Parmelee, D., Feng, P., Ding, I., Gao, F., Gentz, R., Huylebroeck, D., Merregaert, J., Zhang, L. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells.


Key Words: angiogenesis • breast cancer • ECM1 • endothelial cells




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
I. Roodink, G. Kats, L. van Kempen, M. Grunberg, C. Maass, K. Verrijp, J. Raats, and W. Leenders
Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression
Am. J. Pathol., December 1, 2008; 173(6): 1873 - 1881.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Mikaelsson, A. H. Danesh-Manesh, A. Luppert, M. Jeddi-Tehrani, M.-R. Rezvany, R. A. Sharifian, R. Safaie, A. Roohi, A. Osterborg, F. Shokri, et al.
Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
Blood, June 15, 2005; 105(12): 4828 - 4835.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
V Berno, D Porrini, F Castiglioni, M Campiglio, P Casalini, S M Pupa, A Balsari, S Menard, and E Tagliabue
The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1
Endocr. Relat. Cancer, June 1, 2005; 12(2): 393 - 406.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mongiat, J. Fu, R. Oldershaw, R. Greenhalgh, A. M. Gown, and R. V. Iozzo
Perlecan Protein Core Interacts with Extracellular Matrix Protein 1 (ECM1), a Glycoprotein Involved in Bone Formation and Angiogenesis
J. Biol. Chem., May 2, 2003; 278(19): 17491 - 17499.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Hamada, W. H. I. McLean, M. Ramsay, G. H. S. Ashton, A. Nanda, T. Jenkins, I. Edelstein, A. P. South, O. Bleck, V. Wessagowit, et al.
Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1)
Hum. Mol. Genet., April 1, 2002; 11(7): 833 - 840.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The Federation of American Societies for Experimental Biology.